What Jim Cramer is watching to see where the stock market goes next
We don’t know what we want. This week, we will find out what it is that will propel us forward or turn us back after the S & P 500 …
Abbott Laboratories
The S&P 500 tops a record high that ‘clears the charts’ of resistance
The S & P 500 surged to a new all-time high on Friday, confirming the stock market is in a bull market and suggesting the rally has further to go …
We like health-care stocks in 2024 despite presidential election year weakness
As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason …
Citi and others are bullish on biotech, medtech and more
2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. …
Jim Cramer’s 4 stock ideas from JPMorgan Healthcare Conference
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from …
Walgreens and 3 other health-care stocks are going into our Bullpen watch list
We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s …
Follow CEOs at the JPMorgan Healthcare Conference
CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in San Francisco. Taking place from Monday to Thursday, …
AI, wearables and more — these markets are booming as the world ages
The world is aging rapidly, and there are more and more ways to invest in this theme. Shams Afzal, managing director at Carnegie Investment Counsel, noted that 17% of the …
Health sector themes to watch in 2024
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much …
Pfizer weight loss pill joins list of obesity drug flops
Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat …